In The News
Former SU2C cancer patient, Emily Whitehead, 12 years old and five years cancer-free, speaks up about her role as face of cancer immunotherapy.
Melissa Skala, PhD, a 2016 recipient of an SU2C Innovative Research Grant, says the IRG program, with its quick turnaround and emphasis on results, is “the way science should be.”
Nut Consumption May Aid Colon Cancer Survival
Actress Sonequa Martin-Green Joins SU2C In PSA Encouraging Clinical Trial Participation
Stand Up To Cancer Awards $11M Convergence Research Program Using AI to Investigate Immunotherapies